Anterogen.Co.Ltd (065660) — Cash Flow Quality Index

Latest as of March 2023: -7.10x

Anterogen.Co.Ltd (065660) has a Cash Flow Quality Index of -7.10x as of March 2023. Operating cash flow of ₩-265.11 Million is below net income of ₩37.35 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore how much of Anterogen.Co.Ltd's assets are long-term investments to see how much of total assets are deployed in long-term investments.

Cash Flow Quality Index

-7.10x

Operating CF / Net Income

Operating Cash Flow

₩-265.11 Million

KRW

Net Income

₩37.35 Million

KRW

Data as of

Mar 2023

Most recent filing

Anterogen.Co.Ltd Cash Flow Quality Index (2016–2017)

Historical Cash Flow Quality Index for Anterogen.Co.Ltd across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Anterogen.Co.Ltd (065660) tangible equity ratio to evaluate the tangible quality of the company's equity base.

Annual Cash Flow Quality Index for Anterogen.Co.Ltd (2016–2017)

Year-by-year earnings quality comparison for Anterogen.Co.Ltd. For live market cap and the full company financial profile, see Anterogen.Co.Ltd (065660) market capitalisation.

Year	Quality Index	Operating CF (KRW)	Net Income	YoY Change
2017	0.85x	₩379.21 Million	₩446.74 Million	▲ +341.5%
2016	-0.35x	₩-130.65 Million	₩371.66 Million	—

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.